Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
Haematologica|May 4, 2006
Strategies for widening the use of cord blood in hematopoietic stem cell transplantationMarcos de Lima, Elizabeth Shpall
Expert Review of Anticancer Therapy|May 13, 2008
Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaLazaros Lekakis, Marcos de Lima
Leukemia & Lymphoma|September 24, 2020
Improving patient access to modern myeloma therapy in Latin America: first step, know what your problem really isNelson Hamerschlak, Marcos de Lima
Current Opinion in Hematology|September 8, 2011
Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantationBetul Oran, Marcos de Lima
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Preventing acute leukemia relapse after allogeneic transplants: how to move forward?Ashley Rosko, Marcos de Lima
Targeted Oncology|March 20, 2025
CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A PodcastMarcos de Lima, David I Marks
Leukemia & Lymphoma|July 29, 2014
Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?Basem M William, Marcos de Lima
Revista Brasileira De Hematologia E Hemoterapia|March 14, 2014
Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?Paolo F Caimi, Marcos de Lima
Revista Brasileira De Hematologia E Hemoterapia|July 18, 2014
Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndromeDavid C Yao, Marcos de Lima
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Hematopoietic stem cell transplantation for older patients with myelodysplastic syndromesH Joachim Deeg, Marcos de Lima
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
Haematologica|May 4, 2006
Strategies for widening the use of cord blood in hematopoietic stem cell transplantationMarcos de Lima, Elizabeth Shpall
Expert Review of Anticancer Therapy|May 13, 2008
Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaLazaros Lekakis, Marcos de Lima
Leukemia & Lymphoma|September 24, 2020
Improving patient access to modern myeloma therapy in Latin America: first step, know what your problem really isNelson Hamerschlak, Marcos de Lima
Current Opinion in Hematology|September 8, 2011
Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantationBetul Oran, Marcos de Lima
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Preventing acute leukemia relapse after allogeneic transplants: how to move forward?Ashley Rosko, Marcos de Lima
Targeted Oncology|March 20, 2025
CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A PodcastMarcos de Lima, David I Marks
Leukemia & Lymphoma|July 29, 2014
Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?Basem M William, Marcos de Lima
Revista Brasileira De Hematologia E Hemoterapia|March 14, 2014
Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?Paolo F Caimi, Marcos de Lima
Revista Brasileira De Hematologia E Hemoterapia|July 18, 2014
Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndromeDavid C Yao, Marcos de Lima
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Hematopoietic stem cell transplantation for older patients with myelodysplastic syndromesH Joachim Deeg, Marcos de Lima
Pageof 33